about
Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatchesRequirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents.Immune "tolerance profiles" in donor bone marrow infused kidney transplant patients using multiple ex vivo functional assays.Common gamma chain cytokines promote rapid in vitro expansion of allo-specific human CD8+ suppressor T cellsImmune responses and their regulation by donor bone marrow cells in clinical organ transplantation.Toward tolerance to human organ transplants: a few additional corollaries and questions.Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsMicrochimerism in promoting graft acceptance in clinical transplantation.Favorable effects of alemtuzumab on allospecific regulatory T-cell generation.Evaluation of the tolerogenic effects of donor bone marrow cells using a severe combined immunodeficient mouse-human islet transplant model.Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reactionThe human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.Transplant-associated autoimmune mechanisms in human hepatitis C virus infection.Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury.Intragraft Molecular Pathways Associated with Tolerance Induction in Renal Transplantation.Generation and Characterization of Alloantigen-Specific Regulatory T Cells For Clinical Transplant Tolerance.Cellular and functional biomarkers of clinical transplant tolerance.A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil.Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosus.Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contactsIn vitro immunogenicity of cadaver donor bone marrow cells used for the induction of allograft acceptance in clinical transplantationModulatory effects of human donor bone marrow cells on allogeneic cellular immune responsesAnalysis of post-transplant immune status in recipients of liver/bone marrow allograftsDonor bone marrow cells used for the induction of allograft acceptance in clinical transplantation as regulators of autologous immune responsesCells of donor phenotype present in renal transplant recipients infused with donor marrow: potent regulators of antidonor immune responses of the recipientInduction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplantsImmunoregulatory role of chimerism in clinical organ transplantationCellular immune responses of human cadaver donor bone marrow cells and their susceptibility to commonly used immunosuppressive drugs in transplantationImmunophenotyping and cellular immune responses of cadaveric donor bone marrow cellsDifferential resistance of the cellular immune responses and immunoregulatory properties of human cadaveric donor bone marrow cells to immunosuppressive drugs commonly used in transplantationPerioperative donor bone marrow infusion in cadaver kidney transplant recipientsA novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responsesHuman donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cellsKiller cell immunoglobulin-like receptor polymorphisms in HLA-identical kidney transplant recipients: lack of 2DL2 and 2DS2 may be associated with poor graft functionFoxP3 mRNA transcripts and regulatory cells in renal transplant recipients 10 years after donor marrow infusionAbrogation of the alloreactive responses of cadaveric donor intestinal lymphocytes by intraoperative Campath-1H exposureTolerance versus immunosuppression: a perspectiveSpontaneous operational tolerance in kidney transplant recipients
P50
Q28221643-AA33872C-0A7D-437C-A8F4-7E01033EBAE8Q31027865-90920770-7819-4F1F-B7F9-07CFEF3A2DCDQ33790339-29F0D6B9-5E96-46AD-A6A2-44733DAEF247Q33867234-71428629-C75D-4B3B-BDD1-B7C87DBDE1D7Q34110557-93BAFF07-4E18-4EF7-B096-054C7A1695F2Q35216479-E24AED8E-321F-4C32-B667-1D0E97671026Q35743074-0749120A-FF2E-4E82-824C-7AABE72A8871Q35907218-DEB4B2E1-D89D-4B30-9B04-41E62B894AF1Q37888423-3E9AF39A-AE07-4FBD-8873-07D72546CBE9Q40916665-BC92B5E9-FB4C-4E83-A591-8FFD2D1A0698Q41820518-4882B7E4-30E0-4856-819E-CE783AF35E85Q42746133-833FF818-C77D-4F89-BF33-16A6FBA27384Q42954783-A64E0DC4-4313-47E6-ADD3-2C87120D1F61Q42980320-72C2D423-416C-4E4C-872D-B82353D0520FQ43183975-85F3FCE3-3195-42EA-9255-940888E555D7Q45074422-31981465-27BE-45EB-860A-448095ABE85CQ48215037-A0540905-AE03-4E71-AEA0-92C03893AB62Q49644734-16E264BE-8BDF-4208-9453-9595FE5D8BC5Q54216691-3A029732-2215-432F-9718-30D11C960B85Q64965363-7283F46C-4D05-40D9-9C94-DFA97A162FFFQ64986271-14765CDF-B8B0-4D24-9800-2BF465985E2BQ72024369-620A3D76-5883-462B-BBFF-DCB0B9B70139Q73156815-C2214B5A-30EB-4D60-B72A-C8181F5AFA1AQ73167416-28E00DC5-02AD-4B3D-9EDA-6B5C4A9CE188Q73336587-8C6FC2FD-CE53-42B3-8AAE-AFB3C8E1D798Q73667335-71F61A79-4BA3-4C5B-8C03-0711D29CC507Q73667366-7394DAF5-211C-4E2F-91A0-ABD0FDE4BFD5Q73668672-BC4FC980-6BD9-451C-A4CE-369686080788Q74389388-AE5F4847-C857-4686-80D9-D85CC66C7A78Q74494006-3C4B3551-AE97-440B-A1B3-362434B83462Q74571091-36C54555-365D-4884-9A81-34E2031F2488Q74685470-ED09BAB4-7596-4F6B-B7E1-974FEBD88273Q77370553-96305642-12DF-4210-91F3-3CE3A9AE82CCQ78727919-3015007D-F650-4632-8834-85A0F1D19E52Q78733934-19E73D59-5315-44F9-958C-99B6FE909045Q80184243-0ABDAE5B-16C6-4822-83AA-77E54BF93DBEQ80521452-55B2FB53-61F0-418D-A611-6D6C44F1D49AQ81680690-21153E2D-8FB3-4C13-95BD-FC2A1B9EE7EBQ82292571-8E4A50B7-AC9C-4C8C-8DB1-A645B7951A6DQ83450310-F434D6BF-8830-4EC8-96BE-1F199C466C7C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
James M Mathew
@ast
James M Mathew
@en
James M Mathew
@es
James M Mathew
@nl
type
label
James M Mathew
@ast
James M Mathew
@en
James M Mathew
@es
James M Mathew
@nl
prefLabel
James M Mathew
@ast
James M Mathew
@en
James M Mathew
@es
James M Mathew
@nl
P106
P1153
16234378400
P21
P31
P496
0000-0002-5667-750X